Chief Operating Officer Alan Raffensperger to leave Sobi™

Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces that the company and Alan Raffensperger, Chief Operating Officer (COO), have come to the...

Read more

Sobi™ keeps the Partner Products business area as an integral part of the company

Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces that the Partner Products business area will remain an integral part of Sobi’s business...

Read more

Sobi™ discloses payments to the healthcare professionals and healthcare organisations to increase transparency

Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces that the company has made all payments and transfers of value to healthcare professionals...

Read more

Kineret® approved in Canada for the treatment of Neonatal-Onset Multisystem Inflammatory Disease (NOMID)

Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces that Health Canada has approved Kineret® (anakinra) for the treatment of Neonatal-Onset...

Read more

Elocta® approved in the Kingdom of Saudi Arabia for the treatment of haemophilia A

Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces that the Saudi Food & Drug Authority (SFDA) in the Kingdom of Saudi Arabia has approved...

Read more

Orfadin® capsules approved in the Kingdom of Saudi Arabia for the treatment of hereditary tyrosinemia type 1

Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces that the Saudi Food and Drug Administration (SFDA) has approved Orfadin® (nitisinone)...

Read more

Bulletin from Swedish Orphan Biovitrum’s (“Sobi”) Annual General Meeting (AGM)

The Sobi AGM was convened earlier today in Stockholm and voted in favour of the resolutions proposed at the meeting, including:


Adoption of the...

Read more

Guido Oelkers appointed President and CEO at Sobi

Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces that Guido Oelkers has been appointed President and Chief Executive Officer effective as of...

Read more

Sobi opens office in Greece

Swedish Orphan Biovitrum AB (publ) (Sobi™) will today formally open a new office in Athens, Greece.  The launch event will start with a ribbon cutting...

Read more

Sobi publishes its report for the first quarter 2017

Read more

Archive